Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NeoGenomics, Inc.
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
October 08, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
September 23, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
September 11, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Reports Second Quarter 2024 Results
July 29, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
July 09, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
June 13, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
May 28, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Reports First Quarter 2024 Results
April 30, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Announces Senior Leadership Promotions
April 18, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
April 09, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
March 27, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
March 20, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
March 01, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
February 20, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Signs Working with Cancer Pledge in Support of Employees
February 01, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
January 30, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
NeoGenomics, Inc.
Via
Business Wire
Tickers
NEO
NeoGenomics Announces Chief Executive Officer Appointment
July 21, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
July 15, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
June 21, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
June 03, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory
June 03, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Appoints Lynn Tetrault Interim CEO
May 16, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting
May 10, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
May 09, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference
May 05, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Reports Revenue of $117 Million in the First Quarter
April 27, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Exposures
COVID-19
Tickers
NEO
NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay
April 25, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022
April 11, 2022
From
NeoGenomics, Inc.
Via
AccessWire
Tickers
NEO
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.